Epilepsy in Hong Kong: A literature review

Hong Kong Medical Journal

Volumn 10, Issue 3, 2004, Pages 185-189

  Hui, A C F ^a   Kwan, P ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Chinese; Cross cultural comparison; Epidemiology; Epilepsy

Indexed keywords

CLINICAL FEATURE; EPILEPSY; HONG KONG; HUMAN; MEDICAL LITERATURE; MEDICAL RESEARCH; MEDLINE; REVIEW;

EPILEPSY; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HONG KONG; HUMANS;

EID: 2942741034     PISSN: 10242708     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (52)

1. Wang WZ, Wu JZ, Wang DS, et al. The prevalence and treatment gap in epilepsy in China: an ILAE/IBE/WHO study. Neurology 2003;60;1544-5.
2. Fong GC, Mak W, Cheng TS, Chan KH, Fong JK, Ho SL. A prevalence study of epilepsy in Hong Kong. Hong Kong Med J 2003;9:252-7.
3. Li SC, Schoenberg BS, Wang CC, Cheng XM, Zhou SS, Bolis CL. Epidemiology of epilepsy in urban areas of the People's Republic of China. Epilepsia 1985;26:391-4.
4. Tan CT, Lim SH. Epilepsy in South East Asia. Neurol J Southeast Asia 1997;2:11-5.
5. Hui AC, Tang A, Wong KS, Mok V, Kay R. Recurrence after a first untreated seizure in the Hong Kong Chinese population. Epilepsia 2001;42:94-7.
6. Ng KK, Ng PW, Tsang KL; Hong Kong Epilepsy Study Group. Clinical characteristics of adult epilepsy patients in the 1997 Hong Kong epilepsy registry. Chin Med J (Engl) 2001;114:84-7.
7. Cheung CM, Tsoi TH, Au-Yeung M, Tang AS. Epileptic seizure after stroke in Chinese patients. J Neurol 2003;250:839-43.
8. Kwong KL, Chak WK, Wong SN, So KT. Epidemiology of childhood epilepsy in a cohort of 309 Chinese children. Pediatr Neurol 2001;24:276-82.
9. Ma CK, Chan KY. Benign childhood epilepsy with centrotemporal spikes: a study of 50 Chinese children. Brain Dev 2003;25:390-5.
10. Ko CH, Kong CK, Chow TC, Lee KC. Classic late infantile neuronal ceroid lipofuscinosis in a Chinese patient. Hong Kong Med J 2001;7:93-6.
11. Hui AC, Ma RCW, Ozaki R, Kay R, Cockram CC. Seizure recurrence in temporal lobe epilepsy. Int J Clin Pract 2001;56:63-4.
12. Chow KM, Hui CF, Lam CW, et al. Clinical and genetic features of variegate porphyria in a Chinese patient. Chin Med J (Engl) 2001;114:424-7.
13. Hui AC, Wong TY, Chow KM, Szeto CC. Multifocal myoclonus secondary to tranexamic acid. J Neurol Neurosurg Psychiatry 2003;74:547.
14. Heap BJ. Cerebral cysticercosis as a common cause of epilepsy in Gurkhas in Hong Kong. J R Army Med Corps 1990;136:146-9.
15. Wong KL, Woo EK, Yu YL, Wong RW. Neurological manifestations of systemic lupus erythematosus: a prospective study. Q J Med 1991;81:857-70.
16. Mok CC, Lau CS, Wong RW. Neuropsychiatric manifestations and their clinical associations in southern Chinese patients with systemic lupus erythematosus. J Rheumatol 2001;28:766-71.
17. Mak W, Fong JK, Cheung RT, Ho SL. Cost of epilepsy in Hong Kong: experience from a regional hospital. Seizure 1999;8:456-64.
18. Fong CY, Hung A. Public awareness, attitude, and understanding of epilepsy in Hong Kong Special Administrative Region, China. Epilepsia 2002;43:311-6.
19. Lau VW, Lee TM, Ng PK, Wong VC. Psychosocial adjustment of people with epilepsy in Hong Kong. Epilepsia 2001;42:1169-75.
20. Lee MM, Lee TM, Ng PK, Hung AT, Au AM, Wong VC. Psychosocial well-being of carers of people with epilepsy in Hong Kong. Epilepsy Behav 2002;3:147-57.
21. Kwan P, Brodie MJ. Early identification of refractory epilepsy. N Engl J Med 2000;342:314-9.
22. Kwong KL, Sung WY, Wong SN, So KT. Early predictors of medical intractability in childhood epilepsy. Pediatr Neurol 2003;29:46-52.
23. Wong V. Epilepsy in children with autistic spectrum disorder. J Child Neurol 1993;8:316-22.
24. Kwong KL, Wong V. Neurodevelopmental profile of Down syndrome in Chinese children. J Paediatr Child Health 1996;32:153-7.
25. Wong V. West syndrome - The University of Hong Kong experience (1970-2000). Brain Dev 2001;23:609-15.
26. Kwong KL, Lee SL, Yung A, Wong VC. Status epilepticus in 37 Chinese children: aetiology and outcome. J Paediatr Child Health 1995;31:395-8.
27. Hui AC, Joynt GM, Li H, Wong KS. Status epilepticus in Hong Kong Chinese: aetiology, outcome and predictors of death and morbidity. Seizure 2003;12:478-82.
28. Yan Liu X, Wong V. Spectrum of epileptic syndromes with electrical status epilepticus during sleep in children. Pediatr Neurol 2000;22:371-9.
29. Chow KM, Hui AC, Szeto CC, Wang AY, Li PK. A confused uraemic woman. Lancet 2001;357:278.
30. Chow KM, Wang AY, Hui AC, Wong TY, Szeto CC, Li PK. Nonconvulsive status epilepticus in peritoneal dialysis patients. Am J Kidney Dis 2001;38:400-5.
31. Department of Health of Hong Kong SAR. Annual Departmental Report. 2000-2001:132.
32. Chan YW, Woo E, Yu YL. Chronic effects of phenytoin on brain-stem auditory evoked potentials in man. Electroencephalogr Clin Neurophysiol 1990;77:119-26.
33. Kumana CR, Lauder IJ, Chan M, Ko W, Lin HJ. Differences in diazepam pharmacokinetics in Chinese and white Caucasians-relation to body lipid stores. Eur J Clin Pharmacol 1987;32:211-5.
34. Wong V. Open label trial with vigabatrin in children with intractable epilepsy. Brain Dev 1995;17:249-52.
35. Kwong L. Vigabatrin as first line therapy in infantile spasms: review of seven patients. J Paediatr Child Health 1997;33:121-4.
36. Lim SH, Kwan MC, Sjahrir MI, et al. An open label trial of topiramate as adjunctive therapy in Asian patients with refractory partial epilepsy. Neurol J Southeast Asia 2001;6:121-7.
37. Woo E, Chan YM, Yu YL, Chan YW, Huang CY. If a well-stabilized epileptic patient has a subtherapeutic antiepileptic drug level, should the dose be increased? A randomized prospective study. Epilepsia 1988;29:129-39.
38. Ko CH, Kong CK, Tse PW. Valproic acid and thrombocytopenia: cross-sectional study. Hong Kong Med J 2001;7:15-21.
39. Ng KK, Tang KW, Cheung YL, Li PC. Brain MRI of hippocampal volumetry in patients with refractory temporal lobe epilepsy. Chin Med J (Engl) 2000;113:254-6.
40. Hui AC, Lam JM, Chan YL, et al. Role of magnetic resonance imaging for preoperative evaluation of patients with refractory epilepsy. Hong Kong Med J 2003;9:20-4.
41. Hsiang JNK, Wong LKS, Kay R, Poon WS. Vagus nerve stimulation for seizure control: local experience. J Clin Neuroscience 1998;5:294-7.
42. Hui AC, Lam JM, Wong KS, Kay R, Poon WS. Vagus nerve stimulation for refractory epilepsy: long term efficacy and side-effects. Chin Med J (Engl) 2004;117:58-61.
43. Leung GK, Fan YW, Fong KY. Temporal lobe resection for intractable epilepsy: review of 11 cases. Hong Kong Med J 1999;5;329-36.
44. Ho A, Ng KK, Chan CC, Lee TM. Quality of life of people with epilepsy following temporal lobectomy: a preliminary report. Percept Mot Skills 2000;91:1035-9.
45. Roses AD. Pharmacogenetics and the practice of medicine. Nature 2000;405:857-65.
46. van der Weide J, Steijns LS, van Weelden MJ, de Hann K. The effect of genetic polymorphism of cytochrome P450 CYP2C9 on phenytoin dose requirement. Pharmacogenetics 2001;11:287-91.
47. Ameyaw MM, Regateiro F, Li T, et al. MDR1 pharmacogenetics: frequency of the C3435T mutation in exon 26 is significantly influenced by ethnicity. Pharmacogenetics 2001;11:217-21.
48. Sisodiya SM, Lin WR, Harding BN, Squier MV, Thom M. Drug resistance in epilepsy: expression of drug resistance proteins in common causes of refractory epilepsy. Brain 2002;125:22-31.
49. Lai CW, Lai YH. History of epilepsy in Chinese traditional medicine. Epilepsia 1991;32:299-302.
50. Lee TM, Yang SH, Ng PK. Epilepsy in Chinese culture. Am J Chin Med 2001;29:181-4.
51. De Boer HM. "Out of the shadows": a global campaign against epilepsy. Epilepsia 2002;43(Suppl 6):7S-8S.
52. Jacobs MP, Fischbach GD, Davis MR, et al. Future directions for epilepsy research. Neurology 2001;57:1536-42.